logo
Login

IPCA LABORATORIES LTD (IPCALAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Ipca Laboratories is an integrated pharmaceutical company manufacturing branded and generic formulations, APIs and intermediates. Indian branded formulations are its core profit engine, complemented by formulation exports across Europe, Africa, the Americas, Asia, CIS and Australasia. The consolida…

IPCALABUpdated 29 Aug 2026, 2:43

Ipca Laboratories Ltd

Market Cap

₹49,480Cr.

Current Price

₹1,950

High / Low

₹1,992/1,252

Stock P/E

39.1

ROE15.3%
ROCE19.7%
Book Value₹315
Face Value₹1.00
Dividend Yield0.31%

About

Ipca Laboratories is an integrated pharmaceutical company manufacturing branded and generic formulations, APIs and intermediates. Indian branded formulations are its core profit engine, complemented by formulation exports across Europe, Africa, the Americas, Asia, CIS and Australasia. The consolidated business includes Unichem Laboratories and its US, Brazil, Europe and South Africa operations.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days425759686471555659616464
Inventory Days293290288286332312350364293309297336
Days Payable97145128136146133121101807893119
Cash Conversion Cycle238203219218250250284319272293269280
Working Capital Days69627582939110810574878593
ROCE %13%4%9%9%17%20%30%19%11%14%17%20%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:43

Designed & Shipped by Harshit Bansal